Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's

21st January 2025 Uncategorised 0

An observational study from Washington University in St. Louis has shed more light on the benefits—as well as the risks—of using new diabetes and weight loss drugs from Novo Nordisk and Eli Lilly. According to the study, researchers found that use of the new medicines may reduce the risk of Alzheimer’s disease and substance abuse disorders while increasing the risk of digestive issues and arthritis.

More: Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's
Source: fierce